Tyche Industries Ltd Upgraded to Sell on Technical Improvements Despite Challenging Fundamentals

Technical Trends Signal Mild Optimism

The most significant driver behind the upgrade is the improvement in Tyche Industries’ technical grade, which shifted from mildly bearish to mildly bullish. Weekly technical indicators such as the MACD and Bollinger Bands have turned bullish, signalling potential upward momentum in the near term. The weekly KST (Know Sure Thing) indicator also supports this positive trend, while monthly indicators remain mixed with mildly bullish MACD and Bollinger Bands but a bearish KST.

Daily moving averages, however, continue to show a mildly bearish stance, indicating some short-term caution. Dow Theory assessments on both weekly and monthly charts are mildly bullish, suggesting that the stock may be entering a phase of consolidation or gradual recovery. This technical improvement is reflected in the stock’s recent price action, with the current price at ₹140.45, up 4.19% on the day, and a 1-week return of 15.36% compared to the Sensex’s decline of 1.62% over the same period.

Valuation Remains a Concern as Premium Persists

Despite the technical upgrade, Tyche Industries’ valuation grade has deteriorated from expensive to very expensive. The company’s price-to-earnings (PE) ratio stands at 21.62, which is high relative to its modest return on equity (ROE) of 4.77% and return on capital employed (ROCE) of 4.01%. The enterprise value to EBITDA ratio is an elevated 43.21, underscoring the premium investors are paying for earnings that have been under pressure.

Price to book value is near parity at 1.03, but the enterprise value to EBIT ratio is an extreme 117.97, reflecting the company’s depressed earnings base. Dividend yield remains modest at 2.12%, offering limited income support. Compared to peers such as Titan Biotech and Sanstar, which also trade at very expensive valuations, Tyche Industries’ premium is not justified by its financial performance, raising questions about sustainability.

Financial Trends Highlight Ongoing Challenges

Tyche Industries’ financial performance remains a significant drag on its investment appeal. The company has reported very negative results for the third quarter of FY25-26, with net sales declining at an annualised rate of -8.35% over the past five years and operating profit shrinking by -49.08% during the same period. The latest quarterly profit before tax (PBT) fell by -24.42%, continuing a trend of four consecutive quarters of negative results.

Net sales for the latest quarter stood at ₹10.58 crores, down 25.7% compared to the previous four-quarter average, while profit after tax (PAT) for the last six months was ₹3.34 crores, reflecting a steep decline of -63.90%. The PBT excluding other income also fell by -46.4%, underscoring the company’s operational difficulties. These figures contrast sharply with the stock’s positive short-term price momentum, indicating a disconnect between market sentiment and fundamental performance.

Quality Assessment and Market Capitalisation

Tyche Industries is classified as a micro-cap company within the Pharmaceuticals & Biotechnology sector, with a Mojo Score of 40.0 and a current Mojo Grade of Sell, upgraded from Strong Sell. The company is net-debt free, which is a positive from a balance sheet perspective, and promoters remain the majority shareholders, signalling stable ownership.

However, the company’s quality metrics remain weak, with low returns on equity and capital employed, and a lack of consistent profitability. The long-term returns tell a mixed story: while the stock has delivered a remarkable 242.98% return over 10 years, it has underperformed the Sensex over three and five years, with returns of -21.01% and -46.02% respectively, compared to Sensex gains of 22.79% and 54.62% over the same periods.

Balancing Technical Gains Against Fundamental Weaknesses

The upgrade in Tyche Industries’ investment rating to Sell reflects a cautious optimism driven primarily by technical indicators suggesting a mild bullish trend. The stock’s recent outperformance relative to the Sensex, with a 21.18% year-to-date return versus the Sensex’s -10.80%, supports this view. However, the company’s deteriorating financial performance and stretched valuation metrics temper enthusiasm.

Investors should note that while the technical outlook has improved, the company’s fundamentals remain under pressure, with declining sales, profits, and weak returns on capital. The very expensive valuation multiples imply that the market is pricing in a turnaround that has yet to materialise in earnings or cash flow. This disconnect warrants caution, especially given the company’s history of negative quarterly results and poor long-term growth trends.

In summary, Tyche Industries Ltd’s rating upgrade to Sell from Strong Sell is a reflection of improved technical signals and short-term price momentum, but it remains a high-risk proposition due to fundamental weaknesses and valuation concerns. Investors should weigh these factors carefully and consider alternative opportunities within the Pharmaceuticals & Biotechnology sector and broader market.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →